1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid [Yahoo! Finance]
Artivion, Inc. (AORT)
Company Research
Source: Yahoo! Finance
Luckily for you, StockStory helps you navigate which companies are truly worth holding. Keeping that in mind, here is one low-volatility stock that could succeed under all market conditions and two that may not keep up. Rolling One-Year Beta: 0.73 Formerly known as CryoLife until its 2022 rebranding, Artivion (NYSE:AORT) develops and manufactures medical devices and preserves human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Why Does AORT Give Us Pause? Modest revenue base of $422.6 million gives it less fixed cost leverage and fewer distribution channels than larger companies Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of 0.1% for the last five years Underwhelming 2.3% return on capital reflects management's difficulties in finding profitable growth opportunities At $46.32 per share, Artivion trades at 61.8x forward P/E. To fully un
Show less
Read more
Impact Snapshot
Event Time:
AORT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AORT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AORT alerts
High impacting Artivion, Inc. news events
Weekly update
A roundup of the hottest topics
AORT
News
- 1 Profitable Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]Yahoo! Finance
- Assessing Artivion (AORT) Valuation After Strong Recent Returns And Ongoing Net Loss [Yahoo! Finance]Yahoo! Finance
- 1 Healthcare Stock on Our Watchlist and 2 We Ignore [Yahoo! Finance]Yahoo! Finance
- Artivion Continues Building Toward Bigger And Better Things [Seeking Alpha]Seeking Alpha
- Artivion (NYSE:AORT) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=AORT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> froMarketBeat
AORT
Earnings
- 11/6/25 - Beat
AORT
Sec Filings
- 12/17/25 - Form 4
- 12/17/25 - Form 144
- 12/9/25 - Form 4
- AORT's page on the SEC website